Colistimethate (Paddock Laboratories, LLC)
Welcome to the PulseAid listing for the Colistimethate drug offered from Paddock Laboratories, LLC. This Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Paddock Laboratories, LLC |
NON-PROPRIETARY NAME: | COLISTIMETHATE SODIUM |
SUBSTANCE NAME: | COLISTIMETHATE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient] |
ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-04-15 |
END MARKETING DATE: | 2018-06-30 |
Colistimethate HUMAN PRESCRIPTION DRUG Details:
Item Description | Colistimethate from Paddock Laboratories, LLC |
LABELER NAME: | Paddock Laboratories, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/2mL) |
START MARKETING DATE: | 2014-04-15 |
END MARKETING DATE: | 2018-06-30 |
PRODUCT ID: | 0574-0858_b74611e6-fdde-45a1-a535-f482a6fc9e3b |
PRODUCT NDC: | 0574-0858 |
APPLICATION NUMBER: | ANDA065177 |
Other COLISTIMETHATE SODIUM Pharmaceutical Manufacturers / Labelers: